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Portuguese suppliers should not increase the price charged without changing the product because prices 
need to comply with strict regulations and buyers have strong bargaining power
Sources: Team Analysis; 1 Diário da República; 2 European Commission; 3 In-depth Buyers´ Interviews 
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ANALYSIS | Exports Hypothesis
KEY TAKEAWAYS
Increase Price Charged 
with the Same Product
Prices are highly 
regulated and buyers 
have significant 
bargaining power, so, 
exports will not increase 
if prices increase without 
changing the product
Suppliers that increase prices and 
keep products unchanged are 
penalized in public contests
INCREASING PRICE TRANSPARENCY BUYERS’ PRICE SENSITIVITYEUROPE PUBLIC CONTESTS CRITERIA
European Union: the “Transparency
Directive” (89/105/EEC) “aims to ensure the
transparency of measures established by EU
countries to control the pricing and
reimbursement of medical products” 2
United States: the Food and Drug
Administration (FDA) has created a taskforce
to increase transparency. Other legislative
efforts to increase price and quality
transparency are also being made
Public Contest: in the EU, for big purchases,
public buyers need to pre-define technical
and price criteria, for products. Then,
proposals are evaluated and the most
economically favourable suppliers are
invited to negotiate
Legal Burden on Purchases: under EU
Law, in public contests, it is illegal to select a
national offer over an economically better
foreign offer
The Portuguese export destinations 
are implementing regulations to 
increase price transparency
Portuguese Undifferentiated Products: a
great share of the Portuguese offer includes
undifferentiated products, such as
disposables
Buyers have buying and scrutiny power
The buyers of Portuguese products tend to
come from richer countries, so, they have
the capacity to pay higher prices, but are also
more able to scrutinize quality and price
evolution
High competition and buyers’ 
regulatory coverage and scrutiny 
power make price sensitivity high
A1
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ANALYSIS | Exports Hypothesis
Portugal should take advantage of its current R&D investments and education, to increase the quality of 
medical products
Sources: Team Analysis; 1 OCDE - Comext; 2 Statista; 3 IMD study; 4 PISA (OECD); 5 In-depth interviews
Portugal has the potential to increase the quality of its (already good) products. Denmark, which has a high demand for its more
expensive and cutting-edge medical products are proof that there is a demand for quality if Portugal wants to compete in it and raise prices
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KEY TAKEAWAYS
Increase Price Charged 
with the Same Product 
but with Higher Quality
If Portugal increases the 
quality and price of its 
products, it is possible to 




Trade Balance 1 Deficit: € -2.4 bn (2019) Surplus: € 3.9 bn (2019)
R&D in Health 1 9th out of 81 countries with 0.17% of GDP 1st in 81 countries with 0.93% of GDP
Health
Expenditure 2 9.1% of GDP (2018) 10.5% of GDP (2018)
Education 3,4
5th in 63 countries regarding Government expenditure
on education and Portuguese students performed
better than the EU average only in sciences
2nd in 63 countries regarding Government expenditure
on education and students performed better than EU




Portuguese medical products already meet the EU quality
standards, but it can be enhanced
32nd position in the Global Innovation Index
Is the hotspot for world-leading pharmaceuticals,




Pharmaceutical Products Manufacturing: ~€1.2bn Pharmaceutical Products Manufacturing: ~€14.3bn
Average Export 
Price per Tonne 1
Medicines (Therapeutic and Prophylactic use): ~€227
Instruments (Medical and Surgical use): ~€385
Medicines (Therapeutic and Prophylactic use): ~€2 543
Instruments (Medical and Surgical use): ~€1 206
Table 16: Portugal vs Denmark 
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ANALYSIS | Exports Hypothesis
Increasing the diversity of the product mix has proven to be an appropriate solution to increase companies’ 
profitability levels 
Sources: Team Analysis; 1 Companies’ Websites, 2 SABI
Portuguese suppliers offer a wide variety of high-quality medical products, recognized internationally. Bastos e Viegas and ADA are 2 of
the main players with different market approaches: while Bastos e Viegas offers a wide range of products, ADA focuses on a market niche
Executive Summary Methodology Diagnosis Analysis Recommendations Limitations References Appendix
KEY TAKEAWAYS
Increase Price Charged 
by Increasing the 
Product Mix Diversity
The optimal solution may 
lie in increasing the 
diversity of the product 




A conglomerate of 3 companies in the cotton textile transformation
sector, producing medical and surgical material:
• Product Categories: 3 (compresses, diapers, and bandages) 1
• Production Process: vertically integrated, through three
segments/units of the company
Main Portuguese manufacturer of non-active medical devices,
selling to more than 90 countries around the world:
• Product Categories: 14 different products’ categories 1
• Production Process: accounts for several production lines,
vertically integrated
BASTOS E VIEGAS ALBINO DIAS DE ANDRADE (ADA)
• Revenues and EBITDA Margin: in 2019, Bastos e Viegas’ revenues and EBITDA margin were higher than ADA´s












A Graph 26: Revenues and Margin
2019, €m 2
Graph 27: Revenues and EBITDA Growth
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Portuguese suppliers’ efficiency can be enhanced, in particular in what concerns inventory turnover and 
sales per employee, to offer larger production quantities
Sources: Team Analysis; 1 Orbis; 2 Sabi; 3 CSIMarket; * Worldwide
ANALYSIS | Exports Hypothesis
Graph 31 Graph 32 Graph 33
Graph 34 Graph 35













































• Pharmaceuticals: while Hikma’s profitability is above the average
industry profitability, Bial’s profitability is significantly below
• Medical and Surgical Material: both Portuguese companies’
profitability, specially ADA’s, are below industry levels
• Asset Turnover: Hikma uses assets more efficiently than the
industry, while others do not
• Inventory Turnover: the companies are below industry levels
• Sales per Employee: in Portugal, sales per employee are
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KEY TAKEAWAYS
Increase the Quantity 
Offered by Increasing the 
Efficiency of Suppliers
The efficiency of 
Portuguese producers 
can be improved, so that 
companies can be able 
to produce larger 
quantities
Two Portuguese companies in each industry were compared to their respective industry performance, according to the following indicators:
Profit Margins: extent to
which companies are able to
make money
Sales per Employee: efficiency
and productivity of the average
employee in each company
Asset Turnover: companies’
ability to efficiently use their
assets to generate sales
Inventory Turnover: how
fast companies sell their
inventories
A62 P rtuguese companies from each industry wer  compared to their respective industry's performance*, according o the f llowing indicators: 
l i i
ti it
l , in each company
r r: co panies’









EBITDA Margin EBIT Margin Net Margin
Asset Turnover Inventory Turnover
Graph 36
Portugal has the capabilities to increase the quality
of medical products and there is a demand for higher
quality products. Moreover, it has been proven that
increasing the diversity of Portuguese products,
through innovation, increases the company’s profitability
5
RECOMMENDATION 3 | Increase and Communicate Innovation and Quality of Portuguese Offer (1/6)
In order to increase innovation and quality of its medical products, Portugal should develop incentives, establish 
partnerships with universities and communicate its quality, to increase the value of exports
Sources: Team Analysis
Increase the value of exports, by
increasing the price charged from
Portuguese medical products suppliers. It
can be achieved by improving their
quality and diversifying the product mix
Increase Portuguese innovation and quality of the with:
1. Government and European incentives
2. Partnerships with universities and young talent attraction
incentives
3. Communication of Portuguese medical products quality
OBJECTIVE DESCRIPTIONRATIONALE
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Communication of Portuguese medical 
Products’ quality
Government fiscal incentives and grants: 
promotion of fiscal incentives to Portuguese research 
centres to fund health R&D projects University contests: promotion and participation  in 
innovative contests, in collaboration with universities, 
companies, and research centres
Portuguese suppliers' platform: for national medical 
products’ suppliers to present their product catalogue 
with its specific features and certifications:
Government contests: promotion of annual 
monetary awards to innovative Portuguese health 
companies
1. Portuguese quality ranking: quantifies the 
credibility of quality certifications
European non-repayable funds: attraction of non-
repayable health R&D funding from foreign investors “Attract Young Talent” program: development of 
national strategies to increase talent attraction, based 
on best practices
2. Feedback form: monitors buyers’ satisfaction to 
continually improve the product’s quality
International innovative fairs: participation in 
International fairs 
3. Annual rewards to suppliers: incentivizes quality 
competitiveness among Portuguese suppliers
Table 43: Recommendation 3 – Sub-recommendations Description
1 2 3
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More incentives provided by the government and European organizations should be developed, to retain and 
attract research centres to Portugal and stimulate the production 
Sources: Team Analysis; 1 Agência Nacional de Inovação; 2 Fundação para a Ciência e Tecnologia; 3 European Commission
MEASURE DESCRIPTION AND OBJECTIVE ALREADY IN PLACE 1,2,3
IMPACT
Retain Attract Incentivize
Government fiscal incentives: attenuate tax burden from 
Portuguese scientific investments
Tax incentive: SIFDIE (Portuguese Tax 
Incentive System for R&D Business)
Government contests to innovative companies: support 
Portuguese scientific community with monetary awards
Contest in Portugal: Born from knowledge 
Awards
Government grants: stimulate scientific investigation in 
Portuguese research centers
Grant: government grant for R&D projects 
funded by FCT
European non-repayment funds: cover part of the R&D 
initial costs of Portuguese research centers
European funding program: horizon 2020 
Innovation and Investigation
International fairs: increase visibility and credibility of 
Portuguese research centres to receive funds
Presence in German Contest: Techtextil
Innovations Awards
Objective: increase the number of incentives currently existing in Portugal and Europe by:
(1) retaining research centres in Portugal, (2) attracting research centres to Portugal, and (3) incentivizing research centres to produce and discover solutions for
innovative and disruptive medical products
1 | Development of Government and European Incentives 
RECOMMENDATION 3 | Increase and Communicate Innovation and Quality of Portuguese Offer (2/6)
Executive Summary Methodology Diagnosis Analysis Recommendations Limitations References Appendix
Table 44: European and Government Incentives
BEST PRACTICES | Spain (San Sebastian) *
• Strategy: Development of a talent hosting plan in a strategic region (San Sebastian - hub of R&D) for a talent
attraction plan focused on international researchers to work in collaboration with local researchers
• Implementation: The country invested in talent house building, where researchers can rent houses and research
facilities at affordable prices, have access to a “welcome service” that facilitates the researchers’ integration and to
a seek-job guidance service
• How are they attracting young talents? (1) Providing 25 young scientists mobility grants of €1358/month, for
them to develop a research project in talent house facilities and (2) Offering the possibility for young talents to move
into the talent house facilities for 2 months, to collaborate with Talent House’s researchers
• Results: Increased San Sebastian's R&D investment and attracted ~1320 international researchers
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To address the “brain drain” effect, the Portuguese government should develop a talent hosting plan, that will have 
as the main goal of attracting young talented scientists to work in Portugal
Sources: Team Analysis; 1 European Commission; *Check Appendix E8 for best practices
2 | Establishment of Partnerships with Universities
RECOMMENDATION 3 | Increase and Communicate Innovation and Quality of Portuguese Offer (3/6)
Executive Summary Methodology Diagnosis Analysis Recommendations Limitations References Appendix
PORTUGAL SITUATION
• Where to establish? North of Portugal, close to i3S 1 (R&D hub) which will
facilitate the network between health researchers, companies, and universities






replicate the strategy 
adopted by San 
Sebastian: create a 





In 2018, Portugal was 
in the top 5 European 
countries with the 
highest proportion 
of emigrants
searching for better 
job opportunities 1
Figure 12: San Seb. Talent House
Description: incentivize the use of currently available platforms among universities such as H-Innova Health Innovation Hub
Objective: promote a collaborative business environment between universities, research centres and companies to develop innovative products and increase prices
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To increase medical product’s innovation, Portugal should use currently available platforms that connect students
and research centres, in order to find disruptive solutions
Sources: Team Analysis; 1 Times Higher Education; 2 Health Cluster Portugal Membership
2 | Establishment of Partnerships with Universities
RECOMMENDATION 3 | Increase and Communicate Innovation and Quality of Portuguese Offer (4/6)
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ADVANTAGES FOR EACH STAKEHOLDER
• Students: Investigate Innovate Ideas: (1) apply theoretical knowledge into practice; (2) 1st award price of 5000€
• Research Centres: Create patents: (1) access to a low-cost and highly-qualified workforce; (2) access to “fresh minds” to investigate new ideas
• Producers: Produce new products: (1) create innovative products trough the payment of royalties, that increase profitability levels
University Possible courses to collaborate
University 
Ranking 1
Universidade Católica Biotechnology and Innovation 301-400th
Universidade do Porto Biomedical Engineering 401-500th
Universidade de Lisboa Chemical Engineering 501-600th
Universidade de Aveiro Biomedical Materials and Devices; Chemistry 601- 800th 
Universidade Nova de Lisboa Biochemistry for Health 601- 800th 





Biological Experimental Tech. Institute (iBet)
Biomedical Engineering Institute (INEB)
Ricardo Jorge Nacional Institute
Pedro Nunes Institute
Innovation Pole in Polymer Engineering (PIEP)



































Table 45: Possible Universities to Collaborate With Table 46: Possible Research Centres to Collaborate With
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The quality of Portuguese medical products should be communicated through a single online platform which 
aggregates all Portuguese suppliers that meet the quality requirements
Sources: Team Analysis; 1 In-depth interviews
SOLUTION
Improve the 
communication of the 







Portugal has potential 
to increase the quality 




enhance  the 







ONLINE PLATFORM | Features and Objectives





• Contact information: address, 
website, telephone and e-mail 
• Catalogue of products
Increase the Portuguese medical 
suppliers’ quality visibility using a 
single platform to expose a clear profile 




• Step 1: attribute  national and 
international quality certifications to 
each supplier in the platform
• Step 2: rank the suppliers based on 
the quality  certifications´ credibility
• Increase the  quality level of 
Portuguese offer by rewarding 
suppliers annually, according to their 




• Mandatory fulfilment of feedback 
form regarding purchase 
satisfaction, together with a 
classification attribution
• Increase the efficiency of meeting 
client’s quality requirements
• Help buyers choosing the best 
alternative based on the platform's 
reviews and classifications
RECOMMENDATION 3 | Increase and Communicate Innovation and Quality of Portuguese Offer (5/6)
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Table 47: Online Platform Overview
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The action plan to increase and communicate the innovation and quality of Portuguese offer will take between 1 
year to 4 years to implement
Sources: Team Analysis
COSTS AND ACTION PLAN
2021 2022 2023 2024
Nr Tasks StartDate Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
1 Development of Government incentives Q1’2021
1.1 Increase awareness for Portugal’s incentives necessity Q1’2021
1.2 Development of Government and European incentives Q3’2022
2 Establishment of partnerships with universities Q1’2021
2.1. Promotion of innovative contests among interested participants Q1’2021
2.2. Introduction of “Talent House” plan to interested stakeholders Q2’2021
2.3. Construction of “Talent House” Facilities Q1’2022
2.4. Accommodation of first foreign investors Q3’2024
3 Communication of Portuguese medical products’ quality Q1’2021
3.1 Design medical products suppliers platform Q1’2021
3.2 Introduction of the platform to medical products’ buyers Q3’2022
RECOMMENDATION 3 | Increase and Communicate Innovation and Quality of Portuguese Offer (6/6)
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Greece and Bulgaria Czech Republic (South Moravia) Spain (San Sebastian)
Description Collaboration between universities and companies Fostering the quality of its scientific research Attract international researchers (R&D hub)
Timeline 2013 - 2015 2009 - 2020 2011 - 2020
Procedures
Online Job Platform
• Local SMEs and research centres benefit from the
expertise of highly qualified researchers
• Local researchers benefit from having access to
local universities and companies to conduct
scientific investigations
Somopro Grant
• The Government provides grants to
researchers working in South Moravia, which
includes: (1) living allowance, (2) mobility
allowance and (3) travel allowance
Hosting Plan: Talent house facilities
• Exclusively built for talented researchers at
affordable prices
• “Welcome Service” to facilitate integration
• “Seek-job Guidance Service”
Results
• In 2015, more than 1700 qualified candidates
applied for jobs using the platform
• Since 2009, the number of people leaving
Chemnitz looking for job opportunities decreased
• 13 out of 27 foreign researchers using this
programme remained in the country
• 71 researches were conducted from 71
countries
• Since 2011, it has attracted 1325 young
researchers
• Increased region’s investment in R&D as % of
GDP
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European countries are adopting successful strategies to attenuate the “brain drain” effect by attracting talent to 
increase the quality of its medical products and to find innovative solutions in the medical sector
Sources: Team Analysis; 1 European Committee of the regions 
APPENDIX E8 | Recommendation 3 | Best Practices
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Table 65: Recommendation 3 Best Practices
